Terry Murdock
Chief Operating Officer bei G1 THERAPEUTICS, INC.
Vermögen: 447 716 $ am 31.03.2024
Profil
Terry L.
Murdock is currently the Chief Operating Officer at G1 Therapeutics, Inc. He previously worked as the Executive Director-Global Clinical Operations at Ergomed Plc.
From 2001 to 2012, he held the position of Senior Vice President-Clinical Operations at ILEX Oncology, Inc. He also served as the VP & Global Head-Oncology Center for Excellence at IQVIA Holdings, Inc. from 2014 to 2017.
Prior to that, he was the Vice President-Research at The US Oncology Network from 1995 to 2001.
Mr. Murdock completed his undergraduate and graduate degrees at The University of Texas at Austin.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
G1 THERAPEUTICS, INC.
0,20% | 04.01.2024 | 103 638 ( 0,20% ) | 447 716 $ | 31.03.2024 |
Aktive Positionen von Terry Murdock
| Unternehmen | Position | Beginn |
|---|---|---|
| G1 THERAPEUTICS, INC. | Chief Operating Officer | 01.01.2019 |
Ehemalige bekannte Positionen von Terry Murdock
| Unternehmen | Position | Ende |
|---|---|---|
| IQVIA HOLDINGS INC. | Corporate Officer/Principal | 01.07.2017 |
ILEX Oncology, Inc.
 ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | Chief Operating Officer | 01.05.2012 |
| The US Oncology Network | Corporate Officer/Principal | 01.01.2001 |
| ERGOMED | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Terry Murdock
| The University of Texas at Austin | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| G1 THERAPEUTICS, INC. | Health Technology |
| ERGOMED | Commercial Services |
| IQVIA HOLDINGS INC. | Health Services |
| Private Unternehmen | 2 |
|---|---|
ILEX Oncology, Inc.
ILEX Oncology, Inc. BiotechnologyHealth Technology ILEX Oncology, Inc. was a drug development company focused predominantly on accelerated development of drugs for the treatment and prevention of cancer. The company used to offer drug development services on a contract basis to pharmaceutical and biotech companies through its ILEX Oncology Services subsidiary and used to advance a diversified portfolio of anticancer drugs through its ILEX Products subsidiary. It was located in San Antonio, TX. | Health Technology |
| The US Oncology Network |
